• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎诊断后帕金森病发病风险降低:巢式病例对照研究匹配病例和对照。

Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls.

机构信息

Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.

Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden.

出版信息

J Parkinsons Dis. 2021;11(2):821-832. doi: 10.3233/JPD-202418.

DOI:10.3233/JPD-202418
PMID:33682730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8150472/
Abstract

BACKGROUND

Rheumatoid arthritis (RA) and the genetic risk landscape of autoimmune disorders and Parkinson's disease (PD) overlap. Additionally, anti-inflammatory medications used to treat RA might influence PD risk.

OBJECTIVE

To use a population-based approach to determine if there is an association between pre-occurring rheumatoid arthritis (RA) and later-life risk of PD.

METHODS

The study population was 3.6 million residents of Sweden, who were alive during part or all of the follow-up period; 1997-2016. We obtained diagnoses from the national patient registry and identified 30,032 PD patients, 8,256 of whom each was matched to ten controls based on birth year, sex, birth location, and time of follow-up. We determined the risk reduction for PD in individuals previously diagnosed with RA. We also determined if the time (in relation to the index year) of the RA diagnosis influenced PD risk and repeated the analysis in a sex-stratified setting.

RESULTS

Individuals with a previous diagnosis of RA had a decreased risk of later developing PD by 30-50% compared to individuals without an RA diagnosis. This relationship was strongest in our conservative analysis, where the first PD diagnosis occurred close to the earliest PD symptoms (odds ratio 0.47 (CI 95% 0.28-0.75, p = 0.0006); with the greatest risk reduction in females (odds ratio 0.40 (CI 95% 0,19-0.76, p = 0.002).

DISCUSSION

Our findings provide evidence that individuals diagnosed with RA have a significantly lower risk of developing PD than the general population. Our data should be considered when developing or repurposing therapies aimed at modifying the course of PD.

摘要

背景

类风湿关节炎(RA)与自身免疫性疾病和帕金森病(PD)的遗传风险图谱重叠。此外,用于治疗 RA 的抗炎药物可能会影响 PD 的风险。

目的

采用基于人群的方法来确定预先存在的类风湿关节炎(RA)与晚年 PD 发病风险之间是否存在关联。

方法

研究人群为瑞典 360 万居民,他们在随访期间的部分或全部时间内仍存活;1997-2016 年。我们从国家患者登记处获得了诊断,并确定了 30032 名 PD 患者,其中 8256 名患者根据出生年份、性别、出生地点和随访时间与 10 名对照者进行了匹配。我们确定了先前被诊断为 RA 的个体患 PD 的风险降低。我们还确定了 RA 诊断的时间(与索引年的关系)是否影响 PD 风险,并在性别分层的环境中重复了该分析。

结果

与没有 RA 诊断的个体相比,先前诊断为 RA 的个体随后发展为 PD 的风险降低了 30-50%。这种关系在我们的保守分析中最强,其中 PD 的首次诊断发生在最早的 PD 症状附近(优势比 0.47(95%CI 0.28-0.75,p=0.0006);女性的风险降低最大(优势比 0.40(95%CI 0.19-0.76,p=0.002)。

讨论

我们的研究结果提供了证据,表明被诊断为 RA 的个体患 PD 的风险明显低于一般人群。在制定或重新制定旨在改变 PD 病程的治疗方法时,应考虑我们的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/8150472/eb37306a2800/jpd-11-jpd202418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/8150472/4514271d33ab/jpd-11-jpd202418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/8150472/1024dfe91652/jpd-11-jpd202418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/8150472/eb37306a2800/jpd-11-jpd202418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/8150472/4514271d33ab/jpd-11-jpd202418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/8150472/1024dfe91652/jpd-11-jpd202418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/8150472/eb37306a2800/jpd-11-jpd202418-g003.jpg

相似文献

1
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls.类风湿关节炎诊断后帕金森病发病风险降低:巢式病例对照研究匹配病例和对照。
J Parkinsons Dis. 2021;11(2):821-832. doi: 10.3233/JPD-202418.
2
Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.疾病修饰抗风湿药物与帕金森病风险:类风湿关节炎患者的巢式病例对照研究。
Neurology. 2022 Mar 22;98(12):e1273-e1281. doi: 10.1212/WNL.0000000000013303. Epub 2022 Jan 21.
3
Rheumatoid Arthritis and Risk of Parkinson Disease in Korea.韩国类风湿关节炎与帕金森病风险。
JAMA Neurol. 2023 Jun 1;80(6):634-641. doi: 10.1001/jamaneurol.2023.0932.
4
Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid Arthritis.甲状腺素治疗的自身免疫性甲状腺疾病在类风湿关节炎患者发病时的风险。
JAMA Netw Open. 2018 Oct 5;1(6):e183567. doi: 10.1001/jamanetworkopen.2018.3567.
5
Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.早中年时期医院治疗感染与阿尔茨海默病、帕金森病和肌萎缩侧索硬化症风险的关系:瑞典全国性巢式病例对照研究。
PLoS Med. 2022 Sep 15;19(9):e1004092. doi: 10.1371/journal.pmed.1004092. eCollection 2022 Sep.
6
Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study.心血管危险因素早于类风湿关节炎症状出现:一项巢式病例对照研究。
Arthritis Res Ther. 2017 Jun 30;19(1):148. doi: 10.1186/s13075-017-1351-8.
7
Immunosuppressants contribute to a reduced risk of Parkinson's disease in rheumatoid arthritis.免疫抑制剂可降低类风湿关节炎患者帕金森病的发病风险。
Int J Epidemiol. 2022 Aug 10;51(4):1328-1338. doi: 10.1093/ije/dyac085.
8
Reduced Risk of Parkinson Disease in Patients With Rheumatoid Arthritis: A Nationwide Population-Based Study.类风湿关节炎患者帕金森病发病风险降低:一项全国范围内基于人群的研究。
Mayo Clin Proc. 2016 Oct;91(10):1346-1353. doi: 10.1016/j.mayocp.2016.06.023.
9
Parkinsonism in elderly rheumatoid arthritis patients.老年类风湿关节炎患者的帕金森综合征
Clin Ter. 2014;165(1):19-21. doi: 10.7471/CT.2014.1655.
10
Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.类风湿性关节炎和淋巴瘤是否有共同的风险因素?:类风湿性关节炎诊断前后淋巴瘤和癌症风险的比较。
Arthritis Rheum. 2010 May;62(5):1252-8. doi: 10.1002/art.27402.

引用本文的文献

1
Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.合并症及其对帕金森病的影响:当前证据的叙述性概述
Int J Mol Sci. 2025 Mar 24;26(7):2942. doi: 10.3390/ijms26072942.
2
Sjögren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study.干燥综合征与帕金森病的双向两样本孟德尔随机化研究。
PLoS One. 2024 Apr 3;19(4):e0298778. doi: 10.1371/journal.pone.0298778. eCollection 2024.
3
The association between Parkinson's disease and autoimmune diseases: A systematic review and meta-analysis.

本文引用的文献

1
High IQ in Early Adulthood Is Associated with Parkinson's Disease.成年早期高智商与帕金森病有关。
J Parkinsons Dis. 2020;10(4):1649-1656. doi: 10.3233/JPD-202050.
2
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.非甾体抗炎药的使用与 LRRK2 帕金森病的外显率。
Mov Disord. 2020 Oct;35(10):1755-1764. doi: 10.1002/mds.28189. Epub 2020 Jul 14.
3
Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study.病毒肝炎感染与帕金森病的相关性:一项基于人群的前瞻性研究。
帕金森病与自身免疫性疾病的关联:系统评价和荟萃分析。
Front Immunol. 2023 Jan 25;14:1103053. doi: 10.3389/fimmu.2023.1103053. eCollection 2023.
4
Inflammatory rheumatic diseases and the risk of Parkinson's disease: A systematic review and meta-analysis.炎症性风湿性疾病与帕金森病风险:一项系统评价与荟萃分析。
Front Neurol. 2022 Nov 10;13:999820. doi: 10.3389/fneur.2022.999820. eCollection 2022.
5
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.帕金森病中的细菌丁酸与表观遗传改变和抑郁症状有关。
Mov Disord. 2022 Aug;37(8):1644-1653. doi: 10.1002/mds.29128. Epub 2022 Jun 20.
6
Epidemiological Evidence for an Immune Component of Parkinson's Disease.帕金森病的免疫成分的流行病学证据。
J Parkinsons Dis. 2022;12(s1):S29-S43. doi: 10.3233/JPD-223180.
7
Association Between Rheumatoid Arthritis and Risk of Parkinson's Disease: A Meta-Analysis and Systematic Review.类风湿关节炎与帕金森病风险之间的关联:一项荟萃分析与系统评价
Front Neurol. 2022 May 11;13:885179. doi: 10.3389/fneur.2022.885179. eCollection 2022.
8
Autoimmune Disease Associated Variants Convey Risk of Parkinson's Disease in Han Chinese.自身免疫性疾病相关变异体增加汉族人群患帕金森病的风险。
Front Genet. 2022 Mar 30;13:856493. doi: 10.3389/fgene.2022.856493. eCollection 2022.
9
Immunogenetic Determinants of Parkinson's Disease Etiology.帕金森病病因的免疫遗传决定因素。
J Parkinsons Dis. 2022;12(s1):S13-S27. doi: 10.3233/JPD-223176.
10
Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.疾病修饰抗风湿药物与帕金森病风险:类风湿关节炎患者的巢式病例对照研究。
Neurology. 2022 Mar 22;98(12):e1273-e1281. doi: 10.1212/WNL.0000000000013303. Epub 2022 Jan 21.
J Viral Hepat. 2020 Nov;27(11):1171-1178. doi: 10.1111/jvh.13346. Epub 2020 Jul 10.
4
Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.利用人工智能和药物流行病学鉴定帕金森病中具有疾病修饰潜力的药物。
Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):864-872. doi: 10.1002/pds.5015. Epub 2020 May 14.
5
Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease.帕金森病神经炎症的十大未解之谜
Mov Disord. 2021 Jan;36(1):16-24. doi: 10.1002/mds.28075. Epub 2020 May 1.
6
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.2型糖尿病与帕金森病关系的分析:一项系统综述
Parkinsons Dis. 2019 Nov 23;2019:4951379. doi: 10.1155/2019/4951379. eCollection 2019.
7
Inflammatory Bowel Diseases and Parkinson's Disease.炎症性肠病与帕金森病。
J Parkinsons Dis. 2019;9(s2):S331-S344. doi: 10.3233/JPD-191729.
8
The genetic architecture of Parkinson's disease.帕金森病的遗传结构。
Lancet Neurol. 2020 Feb;19(2):170-178. doi: 10.1016/S1474-4422(19)30287-X. Epub 2019 Sep 11.
9
Parkinson's Disease in Women and Men: What's the Difference?帕金森病在男性和女性中的表现有何不同?
J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683.
10
Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade.环境、生活方式与帕金森病:对未来十年预防工作的启示。
Mov Disord. 2019 Jun;34(6):801-811. doi: 10.1002/mds.27720. Epub 2019 May 15.